Early Inflammatory Response
A study published in Science Translational Medicine on the 11th of May this year (2022) suggests that the initial inflammatory response may be vital in avoiding lasting pain. According to experiments, the report indicates that blocking the inflammatory response with medication can prolong musculoskeletal pain.
Researchers discovered that lower back pain in patients with higher inflammation was more likely to diminish after three months than pain in patients with a more subtle reaction. This supports the early use of Oska Pulse as an alternative to pain killer medication. You can see more on this report by clicking on The Scientist.